Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Language
Year range
1.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 944-947, 2013.
Article in Chinese | WPRIM | ID: wpr-749257

ABSTRACT

OBJECTIVE@#To investigate the ubiquitin expression in laryngeal squamous cell carcinoma (LSCC) whether along with local lymph node metastasis, and further study its correlation with local lymph node metastasis and other clinicopathological parameters in laryngeal squamous cell carcinoma.@*METHOD@#We detected the different expression level of ubiquitin in paraffin specimens between 19 cases of LSCC associated with cervical lymph node metastasis LSCC(N+) and 20 cases of LSCC not associated with cervical lymph node metastasis LSCC(N-) by immunohistochemical staining combined with stereology image analysis system. Statistics were analyzed by student test, variance analysis and ROC curve.@*RESULT@#Ubiquitin expression in LSCC(N+) was significantly higher than LSCC(N-) (P < 0.01); their expression level was not correlated with age,history of tobacco, alcohol addiction, clinical stage and primary site,etc.@*CONCLUSION@#Ubiquitin was significantly up-expressed in LSCC(N+) than ILSCC (N-), which may imply that it is one of the important elements in mechanism of lymph node metastasis in LSCC.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Carcinoma, Squamous Cell , Metabolism , Pathology , Head and Neck Neoplasms , Metabolism , Pathology , Laryngeal Neoplasms , Metabolism , Pathology , Lymph Nodes , Pathology , Lymphatic Metastasis , Squamous Cell Carcinoma of Head and Neck , Ubiquitin , Metabolism
2.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 319-322, 2012.
Article in Chinese | WPRIM | ID: wpr-749405

ABSTRACT

OBJECTIVE@#To investigate the synergistic cytotoxicity of TRAIL and paclitaxel on nasopharyngeal cell lines CNE-1 and CNE-2.@*METHOD@#CCK-8 assays the growth inhibition rate of CNE-1 and CNE-2 which was treated with TRAIL or paclitaxel or combination of both. Flow cytometry tests the apoptosis rate of CNE-1 and CNE-2 which was treated with TRAIL or paclitaxel or combination of each other.@*RESULT@#In certain range of time and concentration,TRAIL and paclitaxel inhibited the growth of the cell lines of CNE-1 and CNE-2 in a time-dose dependent manner (P < 0.05). The rate of growth inhibition and apoptosis in TRAIL and paclitaxel combinative group was more significant than that in the TRAIL and paclitaxel singular group (P < 0.05).@*CONCLUSION@#TRAIL and paclitaxel had a synergistic killing effect on NPC cell lines and showed better affection than singular group, which provides a novel and prospective strategy for NPC chemotherapy.


Subject(s)
Humans , Apoptosis , Carcinoma , Cell Line, Tumor , Nasopharyngeal Carcinoma , Nasopharyngeal Neoplasms , Pathology , Paclitaxel , Pharmacology , Receptors, TNF-Related Apoptosis-Inducing Ligand , Pharmacology
3.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 817-820,823, 2009.
Article in Chinese | WPRIM | ID: wpr-598377

ABSTRACT

This study was designed to prove simultaneously blocking both EGFR and COX-2-medi-ated pathways may be an efficient means of inhibiting cancer cell growth in NPC. Method: A combination of tarceva (EGFR-selectivetyrosine kinase inhibitors) with celecoxib(Cox-2 inhibitor) was studied on its effects on cell growth, cell cycle progression, apoptosis and protein expression in CNE-2 cell lines by cell growth assay, flow cy-tometric analysis assay and Western blotting. Result: ①The inhibition rate of cell growth was higher in the group treated with a combination of two agents than that the sum of rates of the two groups treated with only one agent (P0.05). ③The group of combination showed less expressions of p-EGFR and COX-2 than any other group. Conclusion Simultaneously blocking EGFR and COX-2 mediated pathways would significantly in-hibit the growth of CNE-2 cell line, increase G_1 arrest and reduce the expression levels of p-EGFR and COX-2.

4.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 796-799, 2009.
Article in Chinese | WPRIM | ID: wpr-748650

ABSTRACT

OBJECTIVE@#To investigate the expression and significance of Survivin mRNA in xenotransplanted nasopharyngeal carcinoma treated by paclitaxel combined with radiotherapy.@*METHOD@#Xenotransplanted nasopharyngeal carcinoma was established by CNE-2 cell line, then grouped and treated with paclitaxel, radiotherapy, paclitaxel combined with radiotherapy respectively. Xenotransplanted tumor volume was measured; tumor specimens were confirmed by routine hemotoxylin-eosin staining; apoptosis index was assayed by flow cytometry and Survivin mRNA was detected by one step RT-PCR.@*RESULT@#Xenotransplanted tumor growth was significantly inhibited by paclitaxel combined with radiotherapy and its inhibition rate was 99.3%. Compared to control group, apoptosis index was apparently increased in the other three groups (P0.05).@*CONCLUSION@#Paclitaxel combined with radiotherapy can induce significant killing effect in xenotransplanted nasopharyngeal carcinoma; paclitaxel can enhance the radiosensitivity of xenotransplanted nasopharyngeal carcinoma and its mechanism may rely on the down-regulation of Survivin expression.


Subject(s)
Animals , Humans , Mice , Brachytherapy , Cell Line, Tumor , Inhibitor of Apoptosis Proteins , Genetics , Metabolism , Mice, Nude , Nasopharyngeal Neoplasms , Metabolism , Therapeutics , Paclitaxel , Therapeutic Uses , RNA, Messenger , Genetics , Repressor Proteins , Genetics , Metabolism , Survivin , Xenograft Model Antitumor Assays
5.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 817-823, 2009.
Article in Chinese | WPRIM | ID: wpr-748640

ABSTRACT

OBJECTIVE@#This study was designed to prove simultaneously blocking both EGFR and COX-2-mediated pathways may be an efficient means of inhibiting cancer cell growth in NPC.@*METHOD@#A combination of tarceva (EGFR-selective tyrosine kinase inhibitors) with celecoxib (Cox-2 inhibitor) was studied on its effects on cell growth, cell cycle progression, apoptosis and protein expression in CNE-2 cell lines by cell growth assay, flow cytometric analysis assay and Western blotting.@*RESULT@#(1) The inhibition rate of cell growth was higher in the group treated with a combination of two agents than that the sum of rates of the two groups treated with only one agent (P 0.05). (3) The group of combination showed less expressions of p-EGFR and COX-2 than any other group.@*CONCLUSION@#Simultaneously blocking EGFR and COX-2 mediated pathways would significantly inhibit the growth of CNE-2 cell line, increase G1 arrest and reduce the expression levels of p-EGFR and COX-2.


Subject(s)
Humans , Apoptosis , Celecoxib , Cell Division , Cyclooxygenase 2 , Metabolism , ErbB Receptors , Metabolism , Erlotinib Hydrochloride , Pyrazoles , Pharmacology , Quinazolines , Pharmacology , Signal Transduction , Sulfonamides , Pharmacology , Tumor Cells, Cultured
6.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 58-60, 2007.
Article in Chinese | WPRIM | ID: wpr-748900

ABSTRACT

OBJECTIVE@#To investigate the clinical characteristics, therapeutic efficacy and misdiagnosis status of sphenoid sinus malignant tumor in order to improve the diagnosis rate.@*METHOD@#Analysing and summarizing 18 patients with sphenoid sinus malignant tumor in our department from 1996 to 2005.@*RESULT@#The metastatic nasopharyngeal carcinoma is the most of sphenoid sinus malignant tumor,the second is chordocarcinoma and non-Hodgkin lymphoma, its clinical manifestation was headache (78%), sight alteration (50%), cranial nerve palsy (39%), nose bleed (11%); the clinical diagnosis rate was 56%.@*CONCLUSION@#The nasal endoscopy is the convention examination for these patients with sphenoid sinus malignant tumor whose imageology diagnosis is of limitation.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Diagnostic Errors , Endoscopy , Nasopharyngeal Neoplasms , Diagnosis , Pathology , Paranasal Sinus Neoplasms , Diagnosis , Retrospective Studies , Sphenoid Sinus , Pathology
7.
Chinese Journal of Medical Genetics ; (6): 479-483, 2002.
Article in Chinese | WPRIM | ID: wpr-248524

ABSTRACT

<p><b>OBJECTIVE</b>To identify the type of CTGAATCA from -nt.199 to -nt.192 of the cytokeratin 13(CK13) gene 5' flanking region and determine its transcriptional effect on CK13 gene expression.</p><p><b>METHODS</b>The CAT systems were used to assess the effects of different motifs of CK13 gene 5' flanking region on transcription. The clones of pCAT-enhancer with the total length, -nt.207 to +nt.63 and the same length of -nt.207 to +nt.63, but the T, G of -nt.198, -nt.197 being changed to A, T of the CK13 gene 5' flanking region, were constructed and transferred to HeLa cells with the help of lipofectin. Then work was done to detect the instant CAT expression of different clones and evaluate the effects of CTGAATCA of the 5' flanking region on CK13 gene expression. The type of the cis-element of CTGAATCA was identified with electrophoretic mobility shift assay (EMSA) and competition-EMSA.</p><p><b>RESULTS</b>CTGAATCA in the CK13 gene 5' flanking region is an AP1 cis-element by EMSA and competition-EMSA, it promotes CK13 gene expression.</p><p><b>CONCLUSION</b>CTGAATCA from -nt.199 to nt.192 of the CK13 gene 5' flanking region is an AP1 reaction element, not a cAMP reaction element. It promotes transcriptional activity of CK13 gene 5' flanking region.</p>


Subject(s)
Humans , 5' Flanking Region , Genetics , Base Sequence , Binding Sites , Genetics , Binding, Competitive , Chloramphenicol O-Acetyltransferase , Genetics , Metabolism , DNA , Genetics , Metabolism , Electrophoretic Mobility Shift Assay , Gene Expression Regulation , HeLa Cells , Keratins , Genetics , Mutation , Recombinant Fusion Proteins , Genetics , Metabolism , Transcription Factor AP-1 , Metabolism , Transcription, Genetic , Genetics , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL